-
公开(公告)号:US20190029972A1
公开(公告)日:2019-01-31
申请号:US16158608
申请日:2018-10-12
IPC分类号: A61K31/05 , C07D295/088 , C07K2/00 , C07K1/113 , A61K31/197 , A61K31/397 , A61K31/4745 , A61K31/53 , A61K31/515 , A61K31/65 , A61K31/198 , A61K31/4709 , A61K31/40 , A61K31/136 , A61K31/485 , C07D277/82 , A61K31/70 , C07K1/02 , A61K31/7048 , C07D295/26 , A61K31/4045 , A61K31/4353 , A61K51/04 , C07C305/26 , A61K31/473 , A61K38/31 , A61K31/4168 , A61K31/439 , A61K31/56 , A61K31/505 , A61K31/407 , A61K31/655 , A61K31/47 , C07D295/185 , A61K31/5513 , A61K47/54 , A61K31/4245 , A61K31/14
摘要: This application describes a compound represented by Formula (I): YZX1—S(O)(X2)F)m]n (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X1 is a covalent bond or —CH2CH2—, X2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.
-
公开(公告)号:US20180354988A1
公开(公告)日:2018-12-13
申请号:US15746789
申请日:2016-07-14
发明人: Faik Akif Tezcan , Yuta Suzuki
CPC分类号: C07K2/00 , C07K1/306 , C07K2319/00 , C07K2319/21 , C07K2319/60 , C07K2319/735 , C12N9/16 , C12N9/88 , C12N15/1031
摘要: Polypeptide assemblies and building blocks and methods for making them are provided.
-
公开(公告)号:US20180334702A1
公开(公告)日:2018-11-22
申请号:US15983343
申请日:2018-05-18
申请人: SYSMEX CORPORATION
发明人: Noriko Yokose , Masatoshi Suganuma , Kenta Noda , Naoki Nishiyama
IPC分类号: C12Q1/48 , G01N33/68 , C07K2/00 , G01N33/573 , G01N33/50
CPC分类号: C12Q1/485 , C07K14/00 , C12Y207/11022
摘要: Disclosed is a cyclin-dependent kinase substrate including a polypeptide that contains an amino acid sequence represented by formula (1): R1-P (wherein R1 represents a serine residue or a threonine residue, P represents a proline residue, “—” represents a single bond, and the left side represents the N-terminal side), and satisfies the following (a1) and/or (b1): (a1) the second amino acid residue counting from the proline residue toward the N-terminal side in the formula (1) is an aromatic amino acid residue, and/or (b1) at least two amino acid residues from the proline residue toward the C-terminal side in the formula (1) are acidic amino acid residues.
-
公开(公告)号:US10100080B2
公开(公告)日:2018-10-16
申请号:US14348132
申请日:2012-09-28
申请人: ERA BIOTECH, S.A.
发明人: Roser Pallisse Bergwerf , Stefan Robert Schmidt , Didac Marco Feliu , Patricia Karina Carvajal Vallejos
摘要: The present invention relates generally to robust split inteins. The split inteins described herein are active over a large temperature range, including temperatures as low as 0° C., over a wide pH range, and in the presence of chaotropic salts. The split inteins also show high tolerance to sequence variability in fused heterologous polypeptides and therefore are useful in protein purification and engineering techniques.
-
公开(公告)号:US20180258131A1
公开(公告)日:2018-09-13
申请号:US15787140
申请日:2017-10-18
发明人: Carston R. Wagner
IPC分类号: C07H19/23 , C07K4/00 , C07K2/00 , C07H19/167 , C07F9/6561 , C07H1/00 , C07H19/20 , C07H19/10 , C07H19/052 , C07H19/19 , C07H19/16 , C07H19/207
CPC分类号: C07H19/23 , C07F9/6561 , C07F9/65616 , C07H1/00 , C07H19/052 , C07H19/10 , C07H19/16 , C07H19/167 , C07H19/19 , C07H19/20 , C07H19/207 , C07K2/00 , C07K4/00
摘要: The invention provides a compound of formula I: wherein R1-R6 and X have any of the values described herein, as well as pharmaceutical compositions comprising such compounds and therapeutic methods comprising the administration of such compounds.
-
公开(公告)号:US10023900B2
公开(公告)日:2018-07-17
申请号:US14198112
申请日:2014-03-05
申请人: ALK-Abelló A/S
发明人: Ulla Seppälä
IPC分类号: A61K38/00 , A61K38/04 , C07K2/00 , C07K4/00 , C07K5/00 , C07K7/00 , C07K14/00 , C07K16/00 , C07K17/00 , C12Q1/37 , G01N33/68
CPC分类号: C12Q1/37 , G01N33/6848 , G01N2458/15 , G01N2800/24
摘要: The invention relates to method for quantification of the absolute amount of allergen in an allergen sample comprising: a) providing a known amount of one or more allergen calibration standard peptide(s) having a sequence of amino acids which is identical with, and optionally unique for, a sequence to be found in the allergen to be quantified and optionally labelling said allergen calibration standard peptide(s), b) degrading the allergen sample to obtain a mixture of peptides, and optionally labelling said peptides with one or more labelling agent(s), wherein at least the peptides in the degraded allergen sample or the calibration standard peptides are labelled, and if both the peptides in the degraded allergen sample and the allergen calibration standard peptide(s) are labelled, the labelling agent(s) used for labelling the allergen calibration standard peptide(s) are different from the labelling agent(s) used for labelling the peptides of the degraded allergen sample, c) quantifying the absolute amount of allergen by correlating the amount of the allergen calibration standard peptide(s) with the amount of the corresponding peptide(s) of the degraded allergen sample by mass analysis.
-
公开(公告)号:US09994617B2
公开(公告)日:2018-06-12
申请号:US14350263
申请日:2012-10-08
发明人: John Tite , Edward Walker , Catherine Stace , Christian Heinis
IPC分类号: A61K38/10 , A61K38/12 , A61K38/04 , C07K5/00 , C07K7/00 , C07K16/00 , C07K17/00 , C07K7/56 , C07K7/08 , C07K1/00 , C07K2/00 , C07K1/107
摘要: The invention describes a method for selecting a polypeptide ligand having a desired level of specificity for a target, wherein the polypeptide ligand comprises a polypeptide comprising at least three reactive groups, separated by at least two loop sequences, and a molecular scaffold which forms covalent bonds with the reactive groups of the polypeptide such that at least two polypeptide loops are formed on the molecular scaffold, comprising (i) screening at least two different sets of polypeptide ligands against the target, and selecting one or more ligands from each library which interact with the target; (ii) comparing the activity of the selected ligands with one or more paralogues or orthologues of the target; and (iii) further selecting one or more ligands according to their activity towards said one or more paralogues or orthologues; wherein said two or more different sets of ligands differ in the length of the polypeptide loops formed on the molecular scaffold.
-
公开(公告)号:USRE46830E1
公开(公告)日:2018-05-08
申请号:US14659770
申请日:2015-03-17
发明人: Anne-Sophie Droz , Jasmine Schnidrig , Nicole Studer , Stéphane Varray , Corinne Wenger , Oleg Werbitzky
IPC分类号: C07K2/00 , C07K14/815
CPC分类号: C07K14/815
摘要: A novel method for synthesizing a Hirulog peptide is devised.
-
公开(公告)号:US09945867B2
公开(公告)日:2018-04-17
申请号:US14927586
申请日:2015-10-30
CPC分类号: G01N33/6848 , B82Y15/00 , C07K2/00 , G01N30/7233 , G01N30/8665 , G01N30/8675 , G01N33/532 , G01N33/68 , G01N2458/15 , H01J49/0009 , H01J49/0031 , H01J49/0036 , Y10T436/25 , Y10T436/25125
摘要: Quantitation of analytes, including but not limited to peptides, polypeptides, and proteins, in mass spectrometry using a labeled peptide coupled to a reporter, and a universal reporter.
-
公开(公告)号:US09845237B2
公开(公告)日:2017-12-19
申请号:US13148869
申请日:2010-02-26
申请人: Hsian-Rong Tseng , Hao Wang , Shutao Wang , Helen Su , Caius G. Radu , Johannes Czernin
发明人: Hsian-Rong Tseng , Hao Wang , Shutao Wang , Helen Su , Caius G. Radu , Johannes Czernin
IPC分类号: A61K39/395 , A61K31/7088 , A61K31/724 , A61K38/00 , A61K38/54 , A61P35/00 , C07H21/00 , C07H21/02 , C07K14/00 , C07K16/00 , C07K2/00 , C08B37/16 , C12N15/63 , C12N9/96 , B82B3/00 , B82Y30/00 , B82Y40/00 , A61K47/48 , C08G83/00 , A61K47/62 , A61K47/69 , B82Y5/00
CPC分类号: B82B3/00 , A61K47/62 , A61K47/6923 , B82Y5/00 , B82Y30/00 , B82Y40/00 , C08G83/008
摘要: A supramolecular approach has been developed for preparation of size-controllable nanoparticles, from three different molecular building blocks.
-
-
-
-
-
-
-
-
-